Go to AAPM&R home page Go to AAPM&R home page Go to AAPM&R home page
     
Click Here to Search
MEMBER CENTER CONDITIONS & TREATMENT FIND A PM&R PHYSICIAN FOUNDATION FOR PM&R
ARCHIVES OF PM&R
What is a Physiatrist?
About AAPM&R
 
 
  Legislation & advocacy
Regulation
Practice resources
Practice guidelines
Clinical pathways
Performance Measures Resources
State societies
 
Annual Assembly
Medical Education
Physiatrists' Job Board
PASSOR
Residents
Medical Students
Media Room
Industry Opportunities
Contact Us

 

 
Home  |  Legislative, Business and Clinical Practice Issues  |  Regulation  | 
 

Stark II Analysis and Summary

Introduction

A. Overview

The Federal physician self-referral law, generally referred to as the "Stark law," generally prohibits a physician's referral of a Medicare patient to an entity for the provision of certain designated health services if the physician has a financial relationship with the entity. The law is highly technical and complex, and has engendered both confusion and controversy throughout the health care industry. The confusion is based on the complexity of the statute itself, and the failure of the Health Care Financing Administration ("HCFA") to adopt clear and concise regulations as to its applicability. The controversy lies in the simple fact that it either interferes with or regulates a broad array of business and professional arrangements between physicians and other health care providers, often in a manner that affects competition for delivery of ancillary services between physicians and other entities.

The Stark law is separate and distinct from the Federal anti-kickback law and other Federal fraud and abuse authorities which can also be implicated by physician financial arrangements with entities to which they refer Medicare and Medicaid patients. Compliance with the Stark law does not guarantee compliance with other fraud and abuse provisions, and compliance with those other fraud and abuse provisions does not guarantee compliance with the Stark law.

The regulations published January 4, 2001 answer many of the questions that have perplexed physicians, other providers, and their professional advisers for many years. In many respects, they do so in a more liberal and flexible manner than was the case under the January 1998 proposal. At the same time, the new rules remain highly technical, and HCFA provides roughly 100 pages of commentary accompanying their publication. Even with this detail, the January 2001 rule does not complete the regulatory scheme. As noted below, another Stark rulemaking is yet to come.

|back to top|


B. Statutory and Regulatory History

Congressman Pete Stark (D-CA) first proposed a Federal physician self-referral law in 1988, and what became known as "Stark I" was enacted by the Congress in 1989, at the same time Congress overhauled Medicare's physician payment program and adopted the RBRVS fee schedule approach. The Stark I law applied only to clinical laboratory services and became effective with the fee schedule on January 1, 1992. HCFA proposed implementing regulations for Stark I in March of 1992, and these rules were finalized on August 14, 1995. They were codified at 42 C.F.R. 411.350 et seq.

Meanwhile, as part of a major package of Medicare and Medicaid amendments enacted in 1993, the Congress had significantly expanded the Stark law to cover a long list of designated health services in addition to clinical lab services. These amendments, which became effective January 1, 1995, became known as "Stark II."

After a shift in control of the Congress in 1994, Congress reconsidered the statutory scheme it had just enacted. Legislation to significantly pare back Stark II was initiated by the House Ways and Means Committee in 1995, and was ultimately passed by both the House and the Senate as part of a large Medicare and budget bill. However, that bill was vetoed by President Clinton for other reasons, and the issue saw no further action on Capitol Hill for several years.

No implementing regulations were proposed for Stark II until January of 1998. In its January 1998 proposal, HCFA attempted to flesh out the regulatory scheme as applied to the Stark II's longer list of designated services, and in particular, as to the law's applicability to physician group practices. At the same time, HCFA issued implementing regulations establishing an advisory opinion process pursuant to which affected organizations can seek advance rulings from HCFA with respect to particular transactions and arrangements.

The January 1998 proposal was the subject of extensive public comment, and there was strong opposition from the physician community to many aspects of the rules. At the same time, industry representatives took their complaints with the statute and the proposed rules to Capitol Hill. Once again, legislation was introduced to significantly pare back the law. That legislation was not, however, acted upon by either the House or the Senate in the last Congress.

In responding to voluminous comments, and developing what became the January 2001 final rule, HCFA made a policy decision to bifurcate the final Stark II regulations into two phases. The January 2001 rule represents "Phase I." It deals extensively with the key definitions in the law, the provisions dealing directly with group practices, and the general exceptions which protect both ownership and compensation relationships, most important of which is the "in-office ancillary services" exception. In addition, Phase 1 adds several new compensation exceptions, some of which were not previously proposed. What HCFA has not finalized are most of the exceptions relating only to compensation arrangements, proposed in the January 1998 rule, as well as the exceptions which protect only ownership interests. Those provisions will be finalized in a new "Phase II," the future timing of which (like everything associated with Stark!) remains uncertain.

At the same time, by finalizing many of the law's key definitions, the Phase I promulgation does provide considerable guidance with respect to the reach of the law, interpretation of existing Stark I compensation exceptions, and the likely applicability of the Phase II compensation exceptions when finally promulgated.

|back to top|

To next page

 

 

Site Map  •   Contact Us  •   Privacy Policy  •   Disclaimer
330 North Wabash Ave., Suite 2500, Chicago, IL 60611-7617 Copyright ©2008 AAPM&R All Rights Reserved